Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris
Bausch Health, Canada Inc, part of Bausch Health Companies Inc announced that it has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance (pCPA) for Canadian public drug plan coverage for PrCABTREO (clindamycin phosphate, adapalene and …